Hidenori Ohtake

Cutting Edge: Transmembrane Phosphoprotein Csk-Binding Protein/Phosphoprotein Associated With Glycosphingolipid-Enriched Microdomains as a Negative Feedback Regulator of Mast Cell Signaling Through the FcεRI

Hidenori Ohtake, Naoki Ichikawa, Masato Okada et al. · The Journal of Immunology · 2002 · 69 citations · Full text

Negative Feedback Regulator, Glycosphingolipid-enriched Microdomains, Mast Cell Disorder +16

Amelioration of Collagen-Induced Arthritis by a Novel S1P1 Antagonist with Immunomodulatory Activities

Yasuyuki Fujii, Takehiro Hirayama, Hidenori Ohtake et al. · The Journal of Immunology · 2011 · 60 citations · Full text

Immunology, Immunologic Mechanism, Immunotherapy +23

Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors

Yusuke Oka, Tetsuya Yabuuchi, Yasuyuki Fujii et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 25 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +12

Targeting of MIST to Src‐family kinases via SKAP55–SLAP‐130 adaptor complex in mast cells¹

Yasuyuki Fujii, Shunichi Wakahara, Toru Nakao et al. · FEBS Letters · 2003 · 23 citations

Mast Cell Disorder, Immunology, Tumor Biology +19

Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Yusuke Oka, Tetsuya Yabuuchi, Takahiro Oi et al. · Bioorganic & Medicinal Chemistry · 2013 · 21 citations · Full text

Inflammation, Molecular Pharmacology, Medicinal Chemistry +12